Disparities are endemic across our healthcare system. Novartis and the Novartis US Foundation took a major step forward to address the root causes of disparities in health and education by launching Beacon of Hope, an innovative ten-year collaboration initially with 26 Historically Black Colleges and Universities (HBCUs), including four HBCU Medical Schools, plus Merck, Sanofi, the National Medical Association, Thurgood Marshall College Fund, and Coursera. This year, Novartis and the Novartis US Foundation are proud to welcome The Global Black Economic Forum, Advarra, Virb, BeeKeeperAI, Amgen and Alnylam to Beacon of Hope.

Measurable Solutions For Health Equity

The goal of the Beacon of Hope initiative is to co-create effective, measurable solutions for health equity, focusing in three key areas:

Media Release

Novartis expands Beacon of Hope through new collaborations to address systemic health disparities

Read more

Linda Armstrong, US Novartis Foundation President & Lead, US Corporate Responsibility

A Message From Linda

Read about the exciting next chapter for Beacon of Hope from Linda Armstrong, MD, US Novartis Foundation President and Lead, US Corporate Responsibility at Novartis Pharmaceutical Corporation.

Clinical trials pledge signatures

Beacon of Hope Pledge

Stakeholders who signed the original Beacon of Hope Pledge committed to collaboration in finding solutions to addressing systemic disparities in education and health outcomes to create greater diversity, equity and inclusion across the research and development ecosystem.